Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients

Abstract

Physician practice variation may be a barrier to informing hematopoietic cell transplant (HCT) recipients about fertility preservation (FP) options. We surveyed HCT physicians in the United States to evaluate FP knowledge, practices, perceptions and barriers. Of the 1035 physicians invited, 185 completed a 29-item web-survey. Most respondents demonstrated knowledge of FP issues and discussed and felt comfortable discussing FP. However, only 55% referred patients to an infertility specialist. Most did not provide educational materials to patients and only 35% felt that available materials were relevant for HCT. Notable barriers to discussing FP included perception that patients were too ill to delay transplant (63%), patients were already infertile from prior therapy (92%) and time constraints (41%). Pediatric HCT physicians and physicians with access to an infertility specialist were more likely to discuss FP and to discuss FP even when prognosis was poor. On analyses that considered physician demographics, knowledge and perceptions as predictors of referral for FP, access to an infertility specialist and belief that patients were interested in FP were observed to be significant. We highlight variation in HCT physician perceptions and practices regarding FP. Physicians are generally interested in discussing fertility issues with their patients but lack educational materials.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917–2931.

    Article  PubMed  Google Scholar 

  2. Carter A, Robison LL, Francisco L, Smith D, Grant M, Baker KS et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant 2006; 37: 1023–1029.

    CAS  PubMed  Google Scholar 

  3. Gulati SC, Van Poznak C . Pregnancy after bone marrow transplantation. J Clin Oncol 1998; 16: 1978–1985.

    Article  CAS  PubMed  Google Scholar 

  4. Hammond C, Abrams JR, Syrjala KL . Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. J Clin Oncol 2007; 25: 3511–3517.

    Article  PubMed  Google Scholar 

  5. Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001; 358: 271–276.

    Article  CAS  PubMed  Google Scholar 

  6. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045–3052.

    CAS  PubMed  Google Scholar 

  7. Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S et al. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 17: 157–166.

  8. Borgmann-Staudt A, Rendtorff R, Reinmuth S, Hohmann C, Keil T, Schuster FR et al. Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant 2012; 47: 271–276.

    Article  CAS  PubMed  Google Scholar 

  9. Scanlon M, Blaes A, Geller M, Majhail NS, Lindgren B, Haddad T . Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among pre-menopausal women with cancer. J Cancer 2012; 3: 217–225.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol 2009; 27: 5952–5957.

    Article  PubMed  Google Scholar 

  11. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S . Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol 2002; 20: 1890–1897.

    Article  PubMed  Google Scholar 

  12. Knapp CA, Quinn GP . Healthcare provider perspectives on fertility preservation for cancer patients. Cancer Treat Res 2010; 156: 391–401.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kohler TS, Kondapalli LA, Shah A, Chan S, Woodruff TK, Brannigan RE . Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet 2011; 28: 269–277.

    Article  PubMed  Google Scholar 

  14. Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB et al. Discussion of fertility preservation with newly diagnosed patients: oncologists' views. J Cancer Surviv 2007; 1: 146–155.

    Article  PubMed  Google Scholar 

  15. Vadaparampil S, Quinn G, King L, Wilson C, Nieder M . Barriers to fertility preservation among pediatric oncologists. Patient Educ Couns 2008; 72: 402–410.

    Article  PubMed  Google Scholar 

  16. Forman EJ, Anders CK, Behera MA . A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril 2010; 94: 1652–1656.

    Article  PubMed  Google Scholar 

  17. Martins Y, Lederman RI, Lowenstein CL, Joffe S, Neville BA, Hastings BT et al. Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician survey. Br J Cancer 2012; 106: 1021–1026.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. VanGeest JB, Johnson TP, Welch VL . Methodologies for improving response rates in surveys of physicians: a systematic review. Eval Health Prof 2007; 30: 303–321.

    Article  PubMed  Google Scholar 

  19. Hohmann C, Borgmann-Staudt A, Rendtorff R, Reinmuth S, Holzhausen S, Willich SN et al. Patient counselling on the risk of infertility and its impact on childhood cancer survivors: results from a national survey. J Psychosoc Oncol 2011; 29: 274–285.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The Center for International Blood and Marrow Transplant Research is supported by Public Health Service Grant/Cooperative Agreement U24-CA76518 from the National Cancer Institute, the National Heart, Lung and Blood Institute and the National Institute of Allergy and Infectious Diseases ; a Grant/Cooperative Agreement 5U01HL069294 from NHLBI and NCI; a contract HHSH234200637015C with Health Resources and Services Administration (HRSA/DHHS); two Grants N00014-06-1-0704 and N00014-08-1-0058 from the Office of Naval Research; and grants from Allos, Inc.; Amgen, Inc.; Angioblast; Anonymous donation to the Medical College of Wisconsin; Ariad; Be the Match Foundation; Blue Cross and Blue Shield Association; Buchanan Family Foundation; CaridianBCT; Celgene Corporation; CellGenix, GmbH; Children’s Leukemia Research Association; Fresenius-Biotech North America, Inc.; Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc.; Genzyme Corporation; GlaxoSmithKline; HistoGenetics, Inc.; Kiadis Pharma; The Leukemia and Lymphoma Society; The Medical College of Wisconsin; Merck & Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman USA, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Optum Healthcare Solutions, Inc.; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; RemedyMD; Sanofi; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; StemCyte, A Global Cord Blood Therapeutics Co; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; Tarix Pharmaceuticals; Teva Neuroscience, Inc.; THERAKOS, Inc.; and Wellpoint, Inc. The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, or any other agency of the US Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N S Majhail.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Bone Marrow Transplantation website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loren, A., Brazauskas, R., Chow, E. et al. Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant 48, 1091–1097 (2013). https://doi.org/10.1038/bmt.2013.13

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.13

Keywords

This article is cited by

Search

Quick links